- Home
- NBIX vs DRS Comparison
NBIX vs DRS Comparison
Compare NBIX & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DRS
- Stock Information
- Founded
- NBIX 1992
- DRS 1969
- Country
- NBIX United States
- DRS United States
- Employees
- NBIX N/A
- DRS N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DRS Military/Government/Technical
- Sector
- NBIX Health Care
- DRS Industrials
- Exchange
- NBIX Nasdaq
- DRS Nasdaq
- Market Cap
- NBIX 13.2B
- DRS 11.8B
- IPO Year
- NBIX 1996
- DRS N/A
- Fundamental
- Price
- NBIX $139.60
- DRS $41.66
- Analyst Decision
- NBIX Strong Buy
- DRS Strong Buy
- Analyst Count
- NBIX 18
- DRS 7
- Target Price
- NBIX $160.94
- DRS $46.43
- AVG Volume (30 Days)
- NBIX 782.5K
- DRS 976.2K
- Earning Date
- NBIX 10-29-2025
- DRS 10-29-2025
- Dividend Yield
- NBIX N/A
- DRS 0.87%
- EPS Growth
- NBIX 2.97
- DRS 32.60
- EPS
- NBIX 3.39
- DRS 0.94
- Revenue
- NBIX $2,509,900,000.00
- DRS $3,421,000,000.00
- Revenue This Year
- NBIX $20.66
- DRS $11.94
- Revenue Next Year
- NBIX $14.64
- DRS $6.63
- P/E Ratio
- NBIX $40.91
- DRS $44.25
- Revenue Growth
- NBIX 18.42
- DRS 11.43
- 52 Week Low
- NBIX $84.23
- DRS $26.00
- 52 Week High
- NBIX $154.61
- DRS $49.31
- Technical
- Relative Strength Index (RSI)
- NBIX 68.09
- DRS 43.47
- Support Level
- NBIX $133.62
- DRS $40.97
- Resistance Level
- NBIX $137.03
- DRS $42.02
- Average True Range (ATR)
- NBIX 2.36
- DRS 1.12
- MACD
- NBIX 0.83
- DRS 0.19
- Stochastic Oscillator
- NBIX 97.44
- DRS 51.32
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.